Search

Human Action Recognition (HAR) is a current research topic in the field of computer vision that is based on an important application known as video surveillance. Researchers in computer vision have introduced various intelligent methods based on deep learning and machine learning, but they still face many challenges such as similarity in various actions and redundant features. We proposed a framework for accurate human action recognition (HAR) based on deep learning and an improved features optimization algorithm in this paper. From deep learning feature extraction to feature classification, the proposed framework includes several critical steps. Before training fine-tuned deep learning models - MobileNet-V2 and Darknet53 - the original video frames are normalized. For feature extraction, pre-trained deep models are used, which are fused using the canonical correlation approach. Following that, an improved particle swarm optimization (IPSO)-based algorithm is used to select the best features. Following that, the selected features were used to classify actions using various classifiers. The experimental process was performed on six publicly available datasets such as KTH, UT-Interaction, UCF Sports, Hollywood, IXMAS, and UCF YouTube, which attained an accuracy of 98.3%, 98.9%, 99.8%, 99.6%, 98.6%, and 100%, respectively. In comparison with existing techniques, it is observed that the proposed framework achieved improved accuracy. [ABSTRACT FROM AUTHOR]

The early prediction of Alzheimer's disease (AD) can be vital for the endurance of patients and establishes as an accommodating and facilitative factor for specialists. The proposed work presents a robotized predictive structure, dependent on machine learning (ML) methods for the forecast of AD. Neuropsychological measures (NM) and magnetic resonance imaging (MRI) biomarkers are deduced and passed on to a recurrent neural network (RNN). In the RNN, we have used long short-term memory (LSTM), and the proposed model will predict the biomarkers (feature vectors) of patients after 6, 12, 21 18, 24, and 36 months. These predicted biomarkers will go through fully connected neural network layers. The NN layers will then predict whether these RNN-predicted biomarkers belong to an AD patient or a patient with a mild cognitive impairment (MCI). The developed methodology has been tried on an openly available informational dataset (ADNI) and accomplished an accuracy of 88.24%, which is superior to the next-best available algorithms. [ABSTRACT FROM AUTHOR]